Core Viewpoint - The lawsuit against Perrigo Company plc alleges that the company made materially false statements and failed to disclose significant issues regarding its infant formula business, leading to overstated financial results [3]. Group 1: Lawsuit Details - The lawsuit is on behalf of investors who purchased Perrigo securities from February 27, 2023, to November 4, 2025, alleging misleading statements about the infant formula business [3]. - Specific allegations include underinvestment in maintenance and operational improvements, the need for substantial capital expenditures beyond stated estimates, and significant manufacturing deficiencies [3]. Group 2: Financial Impact - On November 5, 2025, Perrigo reported its third-quarter financial results and lowered its full-year guidance due to poor OTC consumption and issues with the infant formula business [4]. - Following this announcement, Perrigo's share price dropped by $5.09, approximately 25.2%, from $20.19 to $15.10 [4].

Core Viewpoint - The Gross Law Firm is notifying shareholders of Perrigo Company plc regarding a class action lawsuit due to alleged misleading statements and operational deficiencies related to the company's infant formula business [1][3]. Group 1: Allegations - The complaint alleges that during the class period from February 27, 2023, to November 4, 2025, Perrigo issued materially false and misleading statements [3]. - Specific allegations include significant underinvestment in the infant formula business acquired from Nestlé, necessitating substantial capital and operational expenditures beyond stated cost estimates [3]. - The complaint also highlights significant manufacturing deficiencies in the infant formula facility, leading to overstated financial results, including earnings and cash flow [3]. Group 2: Class Action Details - Shareholders who purchased PRGO shares during the specified class period are encouraged to register for the class action, with a deadline for lead plaintiff appointment set for January 16, 2026 [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements that inflate stock prices [5].

Core Viewpoint - A class action lawsuit has been filed against Perrigo Company plc and certain officers for alleged violations of federal securities laws during the specified class period from February 27, 2025, to November 4, 2025 [1][2] Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Perrigo securities during the class period [2] - The Complaint alleges that Defendants made materially false and misleading statements and failed to disclose adverse facts about the Company's business and operations [3] - Specific allegations include significant underinvestment in the infant formula business acquired from Nestlé, the need for substantial capital expenditures, and manufacturing deficiencies [8] Group 2: Investor Participation - Investors who suffered losses in Perrigo have until January 16, 2026, to request to be appointed as lead plaintiff [3] - Participation in any recovery does not require serving as lead plaintiff [3] Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC represents investors on a contingency fee basis, meaning they will only be reimbursed for expenses if successful [4] - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud class actions [5]

Core Points - Rosen Law Firm is reminding investors of Perrigo Company plc about the January 16, 2026 deadline to join a securities class action lawsuit related to the company's performance during the class period from February 27, 2023, to November 4, 2025 [2][3] Group 1: Class Action Details - Investors who purchased Perrigo securities during the specified class period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3] - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by January 16, 2026 [4] - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, which suffered from underinvestment and significant manufacturing deficiencies [6] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [5] - The firm has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [5]

Core Viewpoint - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure legal counsel before the January 16, 2026 deadline for a securities class action lawsuit related to the company's performance during the specified class period [2][3]. Group 1: Class Action Details - The class period for the securities class action is from February 27, 2023, to November 4, 2025, inclusive [2]. - Investors who purchased Perrigo securities during this period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3]. - A class action lawsuit has already been filed, and interested parties must move the court to serve as lead plaintiff by January 16, 2026 [4]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience and resources [5]. - The firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its success in securities class action settlements [5]. Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business, including issues related to underinvestment, necessary capital expenditures, and manufacturing deficiencies [6]. - As a result of these misstatements, Perrigo's financial results were overstated, leading to investor damages when the true information became public [6].

Core Points - Rosen Law Firm is reminding investors who purchased Perrigo Company plc securities between February 27, 2023, and November 4, 2025, of the January 16, 2026, lead plaintiff deadline for a class action lawsuit [1][2] Group 1: Class Action Details - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by January 16, 2026 [2] - Investors can join the class action by visiting the provided link or contacting the law firm directly [5] Group 2: Law Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest settlement against a Chinese company at the time [3] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of settlements in 2017 and has consistently ranked in the top 4 since 2013 [3] - In 2019, the firm secured over $438 million for investors, showcasing its effectiveness in recovering funds [3] Group 3: Case Allegations - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment [4] - It is claimed that Perrigo needed to make substantial capital and operational expenditures beyond its stated cost estimates to address issues in the infant formula business [4] - The lawsuit asserts that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results [4]

NEW YORK, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Perrigo Company plc ("Perrigo Company plc" or the "Company") (NYSE: PRGO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Perrigo Company plc investors who were adversely affected by alleged securities fraud between February 27, 2023 and November 4, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1 ...

Core Viewpoint - The Perrigo Company plc is facing a class action lawsuit due to alleged violations of the Securities Exchange Act of 1934, with claims that the company misled investors regarding its financial health and the state of its acquired infant formula business [1][3]. Group 1: Class Action Details - The class action lawsuit is titled French v. Perrigo Company plc and covers securities purchased between February 27, 2023, and November 4, 2025 [1]. - Investors have until January 16, 2026, to seek appointment as lead plaintiff in the lawsuit [1]. - The lawsuit alleges that Perrigo and its executives made false statements and failed to disclose critical issues regarding the infant formula business acquired from Nestlé [3]. Group 2: Allegations Against Perrigo - The complaint states that the acquired infant formula business suffered from significant underinvestment, requiring substantial capital expenditures beyond initial estimates [3]. - Manufacturing deficiencies were reported in the facility, leading to overstated financial results, including earnings and cash flow [3]. - On February 27, 2024, Perrigo disclosed additional costs of $35 million to $45 million for remediation, resulting in a 50% decline in earnings per share compared to the previous year [4]. Group 3: Financial Impact - On May 7, 2024, Perrigo reported net sales of $91 million, a decrease of 34.5%, attributed to lower shipments as the company addressed remediation plans [5]. - The gross margin fell to 36.5%, a decline of 90 basis points, with a significant impact from the infant formula business [5]. - On August 6, 2025, Perrigo's adjusted gross profit decreased by $30 million, or 6.9%, with a reported gross margin of 34.4%, down 260 basis points [6]. Group 4: Strategic Review and Outlook - On November 5, 2025, Perrigo announced a strategic review of its infant formula business and reassessed its previously announced investment of $240 million [7]. - The company slashed its fiscal year 2025 outlook, projecting net sales growth of -2.5% to -3%, down from an expected 0% to 3% [7]. - Expected adjusted diluted earnings per share were revised to a range of $2.70 to $2.80, significantly lower than the previous range of $2.90 to $3.10 [7].

Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1]. Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's infant formula business, acquired from Nestlé, suffered from significant underinvestment in maintenance and operational improvements [2]. - It is alleged that Perrigo needed to make substantial capital and operational expenditures beyond the company's stated cost estimates to remediate issues in the infant formula business [2]. - The complaint also states that there were significant manufacturing deficiencies in the facility for the infant formula business [2]. - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were overstated [2]. - The positive statements made by the defendants regarding the company's business, operations, and prospects were materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Perrigo Company plc during the relevant time frame have until January 16, 2026, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the top securities litigation firms in the United States [4].

Core Points - Rosen Law Firm is encouraging investors of Perrigo Company plc to secure counsel before the January 16, 2026 lead plaintiff deadline for a securities class action lawsuit [2][4] Group 1: Class Action Details - The class period for the lawsuit is from February 27, 2023, to November 4, 2025, during which investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [3][6] - A class action lawsuit has already been filed, and interested parties must move the Court by January 16, 2026, to serve as lead plaintiff, representing other class members [4][6] Group 2: Allegations Against Perrigo - The lawsuit alleges that Perrigo made materially false and misleading statements regarding its infant formula business acquired from Nestlé, which suffered from significant underinvestment and required substantial capital expenditures [6] - It is claimed that there were significant manufacturing deficiencies in Perrigo's infant formula facility, leading to overstated financial results, including earnings and cash flow [6] Group 3: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [5] - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [5]